oligopeptide-106은 임신 중 안전한가요?
No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
성분
oligopeptide-106
알려진 위험 없음100
/100
0
Related ingredients
Frequently asked questions
- oligopeptide-106은 임신 중 안전한가요?
- No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
- oligopeptide-106은 모유 수유 중 안전한가요?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no mechanistic evidence for transfer into breast milk or effects on lactation were identified. Given the lack of adverse signals and expected low dermal/systemic absorption of cosmetic peptides, risk is not indicated for breastfeeding (sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem).
- oligopeptide-106은 아기 피부에 안전한가요?
- No hazard or mechanistic data specific to infants were found. Adult dermal absorption is expected to be negligible for oligopeptides used in cosmetics (adult exposure scored 0), but because infant skin has a less mature barrier and higher surface‑area/weight, exposure scoring is increased by +1 to reflect potentially higher, low but measurable exposure in 0–3‑year‑olds. There is no infant‑specific toxicity evidence to increase hazard or mechanism scores (sources checked: CosIng, PubMed, ECHA Annex VI, PubChem).
- VeriMom은 oligopeptide-106을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 oligopeptide-106을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 oligopeptide-106 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.